投資評価引当金、受取保険金、研究開発費
- 【期間】
| 年度 | 投資評価引当金 | 受取保険金 | 研究開発費 |
|---|
| 2008/03 | -111百万 | | - | | 108億 | |
| 2009/03 | -103百万 | 赤縮 | 55百万 | | 88.3億 | -18.3% |
| 2010/03 | - | | 298百万 | +441.8% | 49.8億 | -43.6% |
| 2010/09 | - | | 10百万 | -96.6% | - | |
| 2011/03 | - | | 36百万 | +260% | 40.7億 | -18.3% |
| 2011/09 | - | | 1百万 | -97.2% | - | |
| 2012/03 | - | | 91百万 | 大幅増 | 38.3億 | -5.9% |
| 2013/03 | - | | 17百万 | -81.3% | 50.3億 | +31.3% |
| 2014/03 | - | | 12百万 | -29.4% | 64.7億 | +28.7% |
| 2015/03 | - | | - | | 67.5億 | +4.5% |
| 2016/03 | - | | - | | 76.3億 | +13% |
| 2017/03 | - | | - | | 87.6億 | +14.8% |
| 2017/12 | - | | - | | 72.2億 | -17.6% |
| 2018/12 | - | | - | | 107億 | +48.2% |
| 2019/12 | - | | - | | 115億 | +7.8% |
| 2020/12 | - | | - | | 125億 | +8.5% |
| 2021/12 | - | | - | | 98.3億 | -21.4% |
| 2022/12 | - | | - | | 107億 | +9.2% |
| 2023/12 | - | | - | | 132億 | +23.4% |
